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Looking Ahead by Looking Back
To help us envision the future of cutaneous biology, we asked senior editorial board members to suggest some of the advances 
published in 2006 that presage further important 
findings for cutaneous research. We comment 
and muse on those findings as we try to predict 
the path of science in the near future. As in 
many recognition endeavors, we are aware this 
article will omit much important work. In this 
process, Journal of Investigative Dermatology 
publications were not excluded; nor was their 
nomination encouraged (our conflict of interest 
statement).
Reductionism and synthesis related to cuta-
neous biology proceeded at a feverish pace in 
2006 and were quite fruitful. With the continual 
maturation of genetics and molecular biology, 
the complexity of the human system becomes 
more precisely elucidated. Piecing together the 
interactions of cells and systems and the regula-
tion of these complex events allows us to begin 
to understand human development and the del-
eterious results of perturbations of the system in 
heritable disease, tumorigenesis, and suscepti-
bility to infectious disease. In turn, these basic-
science discoveries offer immediate clinical 
implications for disease screening and the prom-
ise of treatment in the near future.
The age of genomics has perfected technically 
straightforward approaches for disease gene dis-
covery. Correlations of genotype and phenotype 
provide a wealth of information for understand-
ing the cause of the disease as well as prescribing 
treatment strategies and predicting clinical out-
comes. Several laboratories recently exploited 
genetic approaches to identify or confirm defec-
tive gene products in one devastating rare genet-
ic disease and two common and often debilitat-
ing skin diseases: harlequin ichthyosis, ichthyosis 
vulgaris, and atopic dermatitis. Genetic studies 
implicated an ABC transporter gene in harlequin 
ichthyosis, which is characterized by drastically 
altered epidermal differentiation and impaired 
barrier function, resulting in affected individuals’ 
inability to regulate temperature, resist infection, 
and retain water (Thomas et al., 2006; Rajpar 
et al., 2006; Akiyama et al., 2006). Mutations in 
ABCA12 were identified in a total of 16 patients 
with harlequin ichthyosis, thus establishing 
ABCA12 as the major harlequin ichthyosis gene. 
ABCA12 is a lipid-trafficking molecule involved 
in formation of lamellar bodies to support bar-
rier function, intercellular cohesion, desquama-
tion, and antibacterial defenses. The epidermis 
suffers diseases resulting from primary defects 
in lipid and protein metabolism; one might pre-
dict that new techniques in carbohydrate bio-
chemistry and genetics will lead to an increased 
understanding of these molecules in genetic skin 
diseases in the next few years.
For three decades it has been embarrassing 
to have to admit that the molecular basis of ich-
thyosis vulgaris has still been a work in progress 
when reviewing the ichthyoses for students and 
residents. No more! Filaggrin gene mutations in 
ichthyosis vulgaris show a dose effect and are 
good examples of a semidominant trait. Filaggrin 
is a key protein in facilitating differentiation of 
the epidermis and in maintaining epidermal bar-
rier function. Much more unexpected and very 
welcome was the finding that mutations in filag-
grin are highly associated with atopic dermatitis 
(Palmer et al., 2006; Smith et al., 2006; Irvine 
and McLean, 2006). Generations of research-
ers have focused on immunological defects and 
mechanisms for atopic dermatitis, but the iden-
tification of a heritable defective skin barrier in 
these patients suggests that cutaneous allergen 
exposure may amplify a Th2-type response and 
provoke the onset of atopic disease. The implica-
tions of these findings are also far-reaching for 
asthma and allergy, which are rapidly increasing 
in prevalence in developed nations. The genes 
responsible for these skin diseases provide not 
only useful data for developing prenatal screen-
ing and effective treatments, but also much-
anticipated information for understanding the 
development of the epidermal barrier.
In addition to the insight into epidermal struc-
ture and development offered by these genetic 
studies, investigations of skin morphogenesis 
highlighted a novel developmental regulatory 
mechanism (Yi et al., 2006). More than 100 
microRNAs (miRNAs), which are small noncod-
ing RNAs that bind to 3′ untranslated regions 
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of target mRNAs in a sequence-specific fashion in order to 
influence the translation or stability of the transcripts, were 
cloned from the skin. Yi et al. (2006) demonstrated that 
these miRNAs were differentially expressed in the epider-
mis and hair follicles, presumably to direct development. 
Interestingly, the skin miRNAs could be classified on the 
basis of their predicted targets rather than by their genomic 
location. Therefore, expression of multiple miRNAs with the 
same target reinforces the developmental program via redun-
dant effectors of regulation. Ablation of miRNAs in the skin 
indicated that these regulatory molecules are, in fact, critical 
for skin morphogenesis. This exciting discovery of a previ-
ously unidentified regulatory mechanism will foster a worth-
while new way to explore skin morphogenesis as well as the 
development of other structures.
Research in 2006 also provided enlightenment relat-
ed to infectious disease immunology and cancer. Back in 
1903, Niels Ryberg Finsen was awarded the Nobel Prize in 
Medicine for his demonstration that UV light was beneficial 
to patients with tuberculosis of the skin. More than 100 years 
later, Liu and colleagues (2006) showed the likely molecular 
basis of Finsen’s discovery by demonstrating a link between 
vitamin D and the antimicrobial response to Mycobacterium 
tuberculosis via Toll-like receptor signaling. Upregulation 
of vitamin D synthesis genes resulted in the induction of 
the antimicrobial peptide cathelicidin and may explain the 
diminished vitamin D synthesis capacity and decreased 
cathelicidin induction. The implications of this interesting 
finding extend to consideration of vitamin D administration 
in third-world countries as a mechanism to promote innate 
antimicrobial immune responses. The stage is set for the elu-
cidation of more complex processes in skin physiology. Some 
results will be of classic simplicity and clarity, whereas oth-
ers will be more complicated, requiring investigators to deal 
with the mathematics of system biology modeling.
While UV light exposure induces vitamin D synthesis for 
essential cellular processes, including defense against micro-
bial invaders, these wavelengths are, of course, problematic 
for the epidermal keratinocytes and melanocytes at higher 
doses. In the era of multicenter and multinational trials, it is 
instructive that well-conducted studies of single patients may 
provide important insights. Wang and colleagues (2006) were 
fortunate to follow a female patient with recurrent metastatic 
cutaneous melanoma over the course of a decade. The meta-
static melanoma resulted from clonal derivation from a com-
mon progenitor cell as determined by consistent mutations 
and genetic instabilities. This finding encourages clinicians 
to rethink the use of genotoxic agents to treat these types of 
mutations in order to minimize the genomic instability in the 
clones and, thus, limit the emergence of more biologically 
aggressive clones. Ultimately, this insight may lead to target-
ed and personalized anticancer therapies.
Cis-urocanic acid (cis-UCA) is a recognized sunlight-
induced immunosuppressive factor. One of the earliest 
events of cis-UCA immunouppression is the secretion of 
platelet-activating factor (PAF). Identifying a more proximal 
step in the cis-UCA effector pathway has been elusive. The 
structure of cis-UCA has similarities to that of serotonin. 
Walterscheid and co-workers (2006) showed high affin-
ity binding (Kd = 4.6 nM) of cis-UCA to the serotonin 2A 
receptor. UV and cis-UCA immune suppression in mice 
was blocked with antiserotonin antibodies and serotonin 
2A receptor antagonists. With many serotonin antagonists 
available, this finding opens the door to therapy that could 
be rapidly applied in the clinic.
Even in this small number of studies we are struck by the 
increasing number of authors of these publications and the 
international origin of these advances — a reflection of the 
complexity of disciplines being brought to bear on these 
difficult biological conundrums. Research continues in aca-
demia, industry, and governmental laboratories throughout 
the world, and the effort continues to excite the imagination 
among card-carrying cutaneous biologists and others looking 
for new ways to skin the cat while studying important bio-
logical questions.
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